Related content

Differential response to EGFR- and VEGF-targeted therapies in patient-derived tumor tissue xenograft models of colon carcinoma and related metastases

By                

International Journal of Oncology, Vol. 41, Iss. 2, 2012-01 ,pp. : 583-588

Spandidos Publications

Access to resources Recommend Favorite

Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models

By Chang Yong   Adnane Jalila   Trail Pamela   Levy Joan   Henderson Arris   Xue Dahai   Bortolon Elizabeth   Ichetovkin Marina   Chen Charles   McNabola Angela   Wilkie Dean   Carter Christopher   Taylor Ian   Lynch Mark   Wilhelm Scott  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 561-574

Springer Publishing Company

Access to resources Recommend Favorite

MEDI3617, a human anti-Angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models

By                              

International Journal of Oncology, Vol. 40, Iss. 5, 2012-01 ,pp. : 1321-1330

Spandidos Publications

Access to resources Recommend Favorite

LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice

By Keyes Kristan   Mann Larry   Sherman Michael   Galbreath Elizabeth   Schirtzinger Linda   Ballard Darryl   Chen Yun-Fei   Iversen Philip   Teicher Beverly  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 2, 2004-02 ,pp. : 133-140

Springer Publishing Company

Access to resources Recommend Favorite

Ferumoxtran-10 enhancement in orthotopic xenograft models of human brain tumors: an indirect marker of tumor proliferation?

By Kremer Stéphane   Pinel Sophie   Védrine Pierre-Olivier   Bressenot Aude   Robert Philippe   Bracard Serge   Plénat François  

Journal of Neuro-Oncology, Vol. 83, Iss. 2, 2007-06 ,pp. : 111-119

Springer Publishing Company

Access to resources Recommend Favorite